Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Pascual, T.
3257  Ergebnisse:
Personensuche X
?
1

Prognostic value of HER2DX in early-stage HER2-positive bre..:

Villacampa, G. ; Pascual, T. ; Brasó-Maristany, F....
ESMO Open.  9 (2024)  3 - p. 102388 , 2024
Link: https://doi.org/10.1016/..
 
?
2

LBA3 SOLTI-1507 IPATHER: Primary results of the phase Ib st..:

Oliveira, M. ; Ciruelos, E.M. ; Morales Murillo, S....
ESMO Open.  9 (2024)  - p. 103480 , 2024
Link: https://doi.org/10.1016/..
 
?
3

16P Determinants of response to short preoperative endocrin..:

Bravo, R. Gómez ; Walbaum, B. ; Schettini, F....
ESMO Open.  9 (2024)  - p. 103024 , 2024
Link: https://doi.org/10.1016/..
 
?
4

14P Assessing the predictive value of HER2DX pCR-score for ..:

Martínez-Sáez, O. ; Marin, M. ; Brunet, L. Pare...
ESMO Open.  9 (2024)  - p. 103023 , 2024
Link: https://doi.org/10.1016/..
 
?
5

12P Updated findings from the first prospective HER2DX clin..:

Martínez-Sáez, O. ; Marin, M. ; Hernández-Illán, E....
ESMO Open.  9 (2024)  - p. 103021 , 2024
Link: https://doi.org/10.1016/..
 
?
6

1MO HER2DX assay and survival outcomes: An individual-patie..:

Javierre, G. Villacampa ; Cortés, J. ; García, J.M. Pérez...
ESMO Open.  9 (2024)  - p. 103011 , 2024
Link: https://doi.org/10.1016/..
 
?
7

265TiP SOLTI-2201 ACROSS-TROP2 trial: A phase II study to i..:

Ciruelos, E.M. ; Pascual, T. ; Vazquez, R. Villanueva...
ESMO Open.  9 (2024)  - p. 103286 , 2024
Link: https://doi.org/10.1016/..
 
?
8

13P HER2DX ERBB2 mRNA score in first-line metastatic HER2-p..:

Bayona, R. Sanchez ; Martínez-Sáez, O. ; Romero, D.R....
ESMO Open.  9 (2024)  - p. 103022 , 2024
Link: https://doi.org/10.1016/..
 
?
9

22P Unveiling biological and prognostic differences among p..:

Walbaum, B. ; Chic, N. ; Bruñol, C. Crous...
ESMO Open.  9 (2024)  - p. 103030 , 2024
Link: https://doi.org/10.1016/..
 
?
10

8P Evaluating HER2DX pCR-Score and MRI response in predicti..:

Pascual, T. ; Martínez-Sáez, O. ; Brunet, L. Pare...
ESMO Open.  9 (2024)  - p. 103017 , 2024
Link: https://doi.org/10.1016/..
 
?
11

199P Adoptive PD1+ tumor-infiltrating lymphocyte therapy fo..:

Angelats, L. ; Eslava, M. Santisteban ; Manich, C. Saura...
ESMO Open.  9 (2024)  - p. 103221 , 2024
Link: https://doi.org/10.1016/..
 
?
12

11P Influence of ctDNA variant allele frequency (VAF) on su..:

Fructuoso, I. Garcia ; Martínez-Sáez, O. ; Conte, B....
ESMO Open.  9 (2024)  - p. 103020 , 2024
Link: https://doi.org/10.1016/..
 
?
13

7P Independent validation of HER2DX ERBB2 mRNA score to pre..:

Torres, E. Sanfeliu ; Villacampa, G. ; Pascual, T....
ESMO Open.  8 (2023)  1 - p. 101231 , 2023
Link: https://doi.org/10.1016/..
 
?
14

155TiP A randomised phase II trial of neoadjuvant multi-age..:

Oliveira, M. ; Pascual, T. ; Villacampa, G....
ESMO Open.  8 (2023)  1 - p. 101494 , 2023
Link: https://doi.org/10.1016/..
 
?
15

126MO HER2DX and pathological complete response in HER2-pos..:

Waks, A.G. ; Villacampa, G. ; Brunet, L. Pare...
ESMO Open.  8 (2023)  1 - p. 101465 , 2023
Link: https://doi.org/10.1016/..
 
1-15